Atorvastatin Calcium Tablets, USP, 10 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pha...

FDA Recall #D-0548-2023 — Class II — March 16, 2023

Recall #D-0548-2023 Date: March 16, 2023 Classification: Class II Status: Ongoing

Product Description

Atorvastatin Calcium Tablets, USP, 10 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-946-52

Reason for Recall

CGMP Deviations

Recalling Firm

Northwind Pharmaceuticals LLC — Indianapolis, IN

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

99 bottles

Distribution

Nationwide with the United States

Code Information

Lot # F117192201, Exp. Date 4/30/2023

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated